Pediatric Pharmacotherapy
ثبت نشده
چکیده
Ceftriaxone, a parenteral third generation cephalosporin, was introduced in the United States in 1984. Since that time, it has gained considerable popularity with clinicians providing pediatric health care. With its favorable spectrum of activity, long half-life, ease of administration, and relatively few adverse effects, ceftriaxone has become a frequent choice for empiric antimicrobial therapy in hospitals, emergency departments, and in ambulatory care settings.
منابع مشابه
The Patient Protection and Affordable Care Act: implications for pediatric pharmacy practice.
The impact of the Patient Protection and Affordable Care Act on the pediatric health care landscape includes expanded health insurance coverage and health care delivery improvements by increasing implementation of patient-centered medical homes and accountable care organizations. These offer opportunities for pharmacists to assume responsibility for the medication-related needs of pediatric pat...
متن کاملPharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease.
Pediatric pharmacotherapy is often challenging due to the paucity of available clinical data on the safety and efficacy of drugs that are commonly used in children. This quandary is even more prevalent in children with rare diseases. Although extrapolations for dosing and administration are often made from available adult data with similar disease states, this translation becomes even more prob...
متن کاملPediatric health care quality measures: considerations for pharmacotherapy.
Measuring the quality use of medicines can be conceptualized as a mechanism for understanding appropriate use, underuse, overuse, or misuse. For pediatric pharmacotherapy, measuring the quality use of medicines requires awareness of the differences in health care between children and adults and the differences in the quality and quantity of science that supports evidence-based practice in pedia...
متن کاملAdvances in pharmacotherapy for pediatric anxiety disorders.
Pediatric anxiety disorders are prevalent, chronic, and often lead to significant impaired functioning that impacts both short- and long-term outcomes for children and adolescents. Treatment options include pharmacotherapy and psychosocial interventions. This presentation will review treatment advances specifically for pharmacotherapy. Current research supports serotonin reuptake inhibitors as ...
متن کاملThe effectiveness of Pharmacotherapy on executive actions and Internalizing Behavior Problems in children with attention deficit-hyperactivity disorder: A follow-up study
This article has no abstract.
متن کاملEfficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Although sublingual immunotherapy (SLIT) is accepted to be a viable alternative of specific-allergen immunotherapy, the efficacy of long-term SLIT in asthmatic children is not well established. The efficacy of 3 yr of SLIT in addition to pharmacotherapy was compared with pharmacotherapy alone in a prospective, open, parallel-group, controlled study. Children with asthma aged 4-16 yr, sensitive ...
متن کامل